Skip to main content

Table 3 Biochemical patient characteristics

From: Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics

 

Pediatric HSCT recipients (n = 16)

Normal values

Fasting glucose, mmol/L

5.1 ± 0.8

3.1–6.4

Total cholesterol, mmol/L

4.90 ± 1.20

3.90–7.30

HDL-cholesterol, mmol/L

1.30 ± 0.32

0.80–2.30

LDL-cholesterol, mmol/L

2.69 ± 0.87

0.00–3.37

Triglycerides, mmol/L

1.87 ± 1.29

0.80–2.30

Alanine aminotransferase (ALT), U/L

Men: 32 ± 17

0–45

Women: 15 ± 4

0–34

Aspartate aminotransferase (AST), U/L

Men: 31 ± 16

0–35

Women: 21 ± 2

0–31

Gamma-glutamyl transpeptidase (GGT), U/L

Men: 40 ± 24

0–55

Women: 19 ± 10

0–38

Free thyroxin (FT4), pmol/L

15.9 ± 2.6

12.0–22.0

Thyroid-stimulating hormone (TSH), mU/L

2.695 ± 1.472

0.300–4.800

eGFR (CKD-EPI) > 60 mL/min/1.73m2, n (%)

16 (100%)

NA

Ferritin, μmol/L

Men: 187, 183 (61, 910)

35–260

Women: 31, 437 (8, 792)

10–150

Ferritin > 250 μmol/L, n (%)

5 (31.3%)

NA

Hemoglobin, mmol/L

Men: 9.0 ± 0.7

8.5–11.0

Women: 8.4 ± 0.9

7.5–10.0

  1. Values are presented as numbers (percentages), mean ± standard deviation or median, interquartile range (minimum, maximum), if the distribution was skewed. Separate values are reported for men (n = 11) and women (n = 5), if applicable. HSCT hematopoietic stem cell transplantation